NeurogeneNGNE
那斯達克 · USD
21.78
+0.01
(+0.05%)
收盤 08/02 03:59 (UTC+8)
盤後
21.35
21.35
(-1.97%)
08/02 03:59 (UTC+8)
NeurogeneNGNE
21.78
+0.01
(+0.05%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- 0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | 925 | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | 925 | - | - | - | - | - | - |
營業費用 | 25,919 | 21,512 | 22,180 | 21,059 | 18,779 | 14,733 | -1,863 | 5,165 | 15,135 | 14,251 |
研發費用 | 17,760 | 15,347 | 16,285 | 15,744 | 13,541 | 12,184 | -12,724 | -3,020 | 7,690 | 10,001 |
推銷及管理費用 | 8,159 | 6,165 | 5,895 | 5,315 | 5,238 | 2,549 | 7,443 | 4,767 | 4,027 | 4,250 |
非經常性項目費用 | - | - | - | - | - | - | 3,418 | 3,418 | 3,418 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -25,919 | -21,512 | -22,180 | -20,134 | -18,779 | -14,733 | 1,863 | -5,165 | -15,135 | -14,251 |
其他收入及費用 | 3,274 | 2,000 | 1,966 | 1,646 | 1,861 | 17,119 | 1,440 | 1,137 | 931 | 806 |
利息費用 | 2 | 2 | 3 | 4 | 3 | 3 | -5 | -2 | - | - |
稅前純益 | -22,647 | -19,514 | -20,217 | -18,492 | -16,921 | 2,383 | 3,308 | -4,026 | -14,204 | -13,445 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -22,647 | -19,514 | -20,217 | -18,492 | -16,921 | 2,383 | 3,308 | -4,026 | -14,204 | -13,445 |
基本每股稅後盈餘(元) | -1.08 | -1.00 | -1.19 | -1.09 | -1.00 | - | -2.47 | -2.01 | -2.08 | - |
稀釋每股稅後盈餘(元) | -1.08 | 3.29 | -1.20 | -1.09 | -1.00 | 87.66 | -8.18 | -6.66 | -7.07 | 3.99 |
基本平均股數(千股) | 20996.00 | 19471.00 | 16953.00 | 16941.00 | 16903.00 | - | 5902.00 | 5902.00 | 5902.00 | - |
稀釋平均股數(千股) | 20996.00 | 19471.00 | 16953.00 | 16941.00 | 16903.00 | - | 5902.00 | 5902.00 | 5902.00 | - |
還原基本每股稅後盈餘(元) | -1.08 | -1.00 | -1.19 | -1.09 | -1.00 | - | -9.88 | -8.04 | -8.31 | - |
還原稀釋每股稅後盈餘(元) | -1.08 | 3.29 | -1.20 | -1.09 | -1.00 | 87.66 | -32.72 | -26.66 | -28.28 | 15.96 |
還原基本平均股數(千股) | 20,996 | 19,471 | 16,953 | 16,941 | 16,903 | - | 1,475 | 1,475 | 1,475 | - |
還原稀釋平均股數(千股) | 20,996 | 19,471 | 16,953 | 16,941 | 16,903 | - | 1,475 | 1,475 | 1,475 | - |
EBITDA(千元) | -23,630 | -19,673 | -20,095 | -17,997 | -16,539 | 3,109 | 1,149 | -5,038 | -14,120 | -13,191 |